Macrophage-based cell therapy platform for treating difficult-to-treat, resistant solid tumors. Macrophage Drug Conjugate (MDC) using the TRAIN mechanism delivers active compounds into cancer cell cytoplasm to kill tumor cells and remodel the tumor microenvironment to boost anti-cancer immunity.